Home PEEL Therapeutics

PEEL Therapeutics

In operation
-
Biological New Drug Developer
Basic
Enterprise Profile

Basic Information

PEEL Therapeutics is an emerging biotechnology company established in the United States and Israel, dedicated to developing evolution-based drugs to help patients around the world. PEEL Therapeutics' R&D pipeline originates from assets inspired by the evolution of elephants, plants, and humans, for the treatment of cancer and various inflammatory diseases.
Peel Therapeutics, Inc.
SaltLakeCity,Utah,United States of America
less than 15 people
January 01, 2015
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Tumor Infectious Diseases Therapeutic Products
Application Scenarios
Innovative Drugs